Covered recipient · General Payments record
LAUREN N HRUSZKEWYCZ
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$876.79
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $385.11 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $158.41 | 11 |
| Novo Nordisk AS | $102.70 | 6 |
| DEXCOM, INC. | $22.02 | 1 |
| Exact Sciences Corporation | $19.88 | 1 |
| Astellas Pharma US Inc | $19.61 | 1 |
| Acerta Pharma LLC | $16.56 | 1 |
| Lilly USA, LLC | $15.75 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.26 | 1 |
| PFIZER INC. | $14.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.37 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103945413 | CMS |
| ABBVIE INC. | $6.13 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103945415 | CMS |
| ABBVIE INC. | $7.13 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103945417 | CMS |
| ABBVIE INC. | $17.81 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103945419 | CMS |
| ABBVIE INC. | $9.32 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103945421 | CMS |
| ABBVIE INC. | $16.67 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103945423 | CMS |
| ABBVIE INC. | $15.26 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103945425 | CMS |
| ABBVIE INC. | $2.17 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103945427 | CMS |
| ABBVIE INC. | $31.42 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103945429 | CMS |
| ABBVIE INC. | $17.26 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103945431 | CMS |
| ABBVIE INC. | $26.87 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103945433 | CMS |
| Astellas Pharma US Inc | $19.61 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139342962 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.56 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104546998 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $15.26 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086254252 | CMS |
| Dexcom, Inc. | $22.02 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153315938 | CMS |
| Exact Sciences Corporation | $19.88 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114708868 | CMS |
| Lilly USA, LLC | $15.75 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135128172 | CMS |
| Novo Nordisk Inc | $16.96 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096838017 | CMS |
| Novo Nordisk Inc | $15.54 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097271665 | CMS |
| Novo Nordisk Inc | $14.94 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097577633 | CMS |
| Novo Nordisk Inc | $22.90 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097557962 | CMS |
| Novo Nordisk Inc | $18.92 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096661484 | CMS |
| Novo Nordisk Inc | $13.44 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097836714 | CMS |
| PFIZER INC. | $14.92 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131209615 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.